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Outcome at 4.5 years of children born after expectant
management of early-onset hypertensive
disorders of pregnancy
Aleid G. van Wassenaer, MD, PhD; Jolanda Westera, MSC; Petra E. M. van Schie, PhD; Bregje A. Houtzager, PhD;
Anneke Cranendonk, RN; Laila de Groot, PhD; Wessel Ganzevoort, MD, PhD; Hans Wolf, MD, PhD;
Johanna I. P. de Vries, MD, PhDOBJECTIVE: The objective of the study was to describe neurodevelop-
mental outcome at the age of 4.5 years in 216 children, born after ex-
pectant management of severe early-onset hypertensive complications
of pregnancy.
STUDY DESIGN: This was a prospective follow-up study until age 4.5
ears from maternal admission onward. Developmental outcome mea-
urements included child intelligence quotient and behavioral, motor,
nd neurological outcome. Abnormal composite outcome (perinatal
ortality or abnormal developmental outcome) was studied in relationo gestational age (GA), birthweight (BW), and perinatal variables.
hypertensive disorders of pregnancy. Am J Obstet Gynecol 2011;204:510.e1-9.
0002-9378/$36.00 • © 2011 Mosby, Inc. All rights reserved. • doi: 10.1016
510.e1 American Journal of Obstetrics& Gynecology JUNE 2011RESULTS: Fetal and neonatal mortality was 9% and 8%, respectively. Of
the 178 survivors, 149 (84%) were seen for follow-up. Mean GA was 31.4
weeksand90%wereborngrowth restricted. Abnormal developmental out-
come occurred in 20% and abnormal composite outcome in 37%.
CONCLUSION: Perinatal mortality or abnormal child development oc-
curs in one third of pregnancies with early-onset and severe hyperten-
sive complications and is highest in the lowest GA and BW ranges.
Key words: child outcome, early-onset preeclampsia, intelligence
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wIn early and severe hypertensive com-plications of pregnancy, treatment
strategies have to balance between ma-
ternal and infant risks. A large number of
cohort studies describe maternal and in-
fant outcome after expectant manage-
ment, aiming to carefully prolong preg-
nancy and thereby improve perinatal
outcome without jeopardizing maternal
safety, and a smaller number describe
outcome after interventionist manage-
ment, in which delivery is planned
within 48 hours, aftermaternal stabiliza-
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view, it appears that maternal complica-
tionswere infrequent and similar in both
expectant and interventionist strategies,
whereas maternal death was absent in
these studies. Perinatal mortality and
neonatal morbidity tended to be higher
after interventionist care. A major dis-
advantage of these studies was the re-
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Dutch National Health Insurance Board (Grant/j.ajog.2011.02.032striction to short-term infant outcome,
whereas it is well known that short-term
outcome measures are a poor predictor
of a long-term outcome.2More recently,
t was suggested that expectant manage-
ent was associated with increased ma-
ernal complications at a gestation of 32
eeks or longer.3
Most reports on child outcome in re-
lation to maternal hypertensive compli-
cations of pregnancy collect pregnancy
data retrospectively. As a result, prec-
ise data regarding underlying maternal
morbidity, classification of disease, ma-
ternal treatment strategies, prematurity
and fetal growth restriction, and fetal
monitoring are lacking.4-10 Often litera-
ture on outcome after small-for-gesta-
tional-age (SGA) status at birth is re-
ferred to, but not all infants born SGA
are also growth restricted and vice
versa.11-13
This study presents the long-term de-
velopmental outcome, including cogni-
tion, neurological, and motor and be-
havioral outcome, in a, from maternal
admission onward, prospective cohort
of children born after expectantmanage-Ch
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www.AJOG.org Obstetrics Researchders of pregnancy. The aim was to
describe child outcomes including peri-
natal death and explore the associations
of long-term outcomes with maternal
and neonatal morbidity.
MATERIALS AND METHODS
Participants and the PETRA project
All mothers participated in the Pre-ec-
lampsia Eclampsia TRial Amsterdam
(PETRA) study. The PETRA study was a
randomized clinical trial that compared
expectant management with or without
plasma volume expansion in case of se-
vere and early-onset hypertensive disor-
ders of pregnancy.14 Inclusion criteria of
he PETRA study were a viable singleton
regnancy at a gestational age between
4 and 34 completedweeks, complicated
y fetal growth restriction in combina-
ion with pregnancy-induced hyperten-
ion, severe preeclampsia, HELLP (he-
olysis, elevated liver enzymes, and low
latelet count) syndrome, or eclampsia
definitions in Table 1).
The study took place in 2 tertiary care
enters (ie, theAcademicMedicalCenter
nd the Vrije Universiteit Medical Cen-
er, both located in Amsterdam, The
etherlands), in the period between
pril 1, 2000, and May 31, 2003. Of 216
atients included in the PETRA trial, 111
omen were randomized to the plasma
olume expansion group and 105 women
o the control group. Details of the ran-
omization process and original study
esign have been described elsewhere.15,16
The primary endpoint of the trial was a
neurological assessment at corrected
TABLE 1
Definitions of inclusion criteria of t
Inclusion diagnosis
Severe preeclampsia
...................................................................................................................
HELLP syndrome14
...................................................................................................................
Fetal growth restriction and
pregnancy-induced hypertension
...................................................................................................................
HELLP, hemolysis, elevated liver enzymes, and low platelet co
vanWassenaer. Child outcome after severe hypertensive pterm age.In all cases, there was expectant man-
agement, which consisted of intensive
monitoring of fetal and maternal condi-
tion. Corticosteroids were administered
to patients if delivery was thought to be
imminent before 33weeks, based onma-
ternal disease deterioration or estimated
fetal condition. All but 3 mothers of in-
fants, who were delivered alive before 33
weeks, had been given corticosteroids.
Fetal indications for delivery were re-
peated decelerations or prolonged low
variability on fetal heart rate tracings.
Maternal indicationswere therapy-resis-
tant hypertension, pulmonary edema,
and recurrent HELLP syndrome. Deci-
sions to abstain from intervention were
made, after extensive discussions be-
tween obstetricians, neonatologists, and
parents if fetuses were deemed nonviable
according to individualized assessments
and predefined criteria.
From the 216 mother/child pairs en-
rolled in our trial, 174 children remained
for follow-up at age 4.5 years (Figure 1).
They were all invited for follow-up
assessments.
There were no statistically significant
differences in primary and secondary
maternal or neonatal short-term out-
comes or 1 year child development be-
tween randomization groups; therefore,
we intended to study 4.5 year outcome
irrespective of trial allocation, after it had
been checked that also at 4.5 year out-
comes were not different between study
groups.
Birthweight ratio (BWR) was calcu-
lated by birthweight divided by the ex-
pectedweight for gestation age, using the
study
nition
stolic blood pressure 110 mm Hg and
teinuria (0.3 g per 24 h)
..................................................................................................................
telet count 100/109 per liter and aspartate
inotransferase 70 U/L and lactate
ydrogenase 600 U/L
..................................................................................................................
imated fetal weight p10 and diastolic
od pressure 90 mm Hg
..................................................................................................................
ancy complications. Am J Obstet Gynecol 2011.Gardosi customized growth chart p50
JUNE 2011 Americvalue.17 Major maternal morbidity was
efined as eclampsia, encephalopathy,
ulmonary edema, liver hematoma,
lacental abruption, severe infectious
orbidity, and severe thrombotic mor-
idity. Major neonatal morbidity was
efined as chronic lung disease, grades 3
nd 4 cerebral hemorrhage, grades 2 or
igher periventricular leucomalacia, or
ydrocephalus.
Follow-up procedures
At the corrected age of 4.5 years, the par-
ticipating families were asked to visit 1 of
the 2 outpatient follow-up clinics for se-
quential assessment of child intelligence,
motor development, and neurological
outcome. The parents were asked to
complete a questionnaire about their
child’s behavior (see the following text).
Intelligence quotient (IQ) was as-
sessed using the Revised Amsterdam
Child Intelligence Test (RAKIT), short
form.18 The short form for children aged
4 years 2 months to 5 years 2 months
years consists of 5 subtests,measuring vi-
sual perception, logical reasoning, word
knowledge, visuomotor integration, and
word fluency. This test was standardized
for the Dutch and Flemish population in
the early 1980s.
The standardized IQ index has amean
of 100. The IQ index ranges from 56 to
145. The correlation of the short version
with the complete test is 0.93. Although
qualitatively an excellent test, RAKIT
norms have become outdated. In accor-
dance with the literature on the Flynn ef-
fect,19,20 it is estimated that the mean IQ
n intelligence tests improves about 3-5
oints each decade. We therefore used a
ean of 108 IQ index points as an esti-
ated contemporary population mean.
In a recent study on school outcome of
oderately preterm children, a mean of
08 was indeed found for the term con-
rol group.21With a population SD of 15
ndex points, an IQ score of 93 or greater
as classified as normal development, a
core between 78 and 92 was classified as
oderately delayed, and a score below
8 was classified as abnormal.
Motor assessment
Motor development was examined usinghis
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The M-ABC measures motor functioning
indaily life. A score above the 15thpercen-
tile is considered normal; a score between
the 15th and the 5th percentile is consid-
ered at risk and a score below the 5th per-
centile is considered abnormal.
Neurological assessment
Neurological development was assessed
by using a method adapted from Tou-
wen’s examination of the child with mi-
nor neurological dysfunction.23,24 This
xamination focuses on (minor) signs of
eurological dysfunction. It examines
and function, quality of walking, pos-
ural control, passive muscle tone, and
oordination. The child’s outcome was
xpressed as a percentage of the optimal
core. Performance was rated as normal
75-100%), nonoptimal (50-74%), or
bnormal (50%). Cerebral palsy was
iagnosed according to the latest stan-
ardized definitions.25
Behavior
The child’s behavioral and emotional
functioning was assessed with the Child
Behaviour Check List (CBCL) for ages
1.5-5 years (CBCL 1.5-5).26 The CBCL
1.5-5 is a parent report form that consists
of 99 statements about the child’s behav-
ior. It yields scores for internalizing and
externalizing behavior problems and a
total problem score. Higher scores rep-
resent more behavior problems. Total
problem scores are defined as normal
(82nd percentile), moderately prob-
lematic (82nd and 90th percentile), or
abnormal (90th percentile).
Definition of subnormal and abnormal
developmental outcome and
abnormal composite outcome
Developmental outcome was scored if
at least 2 development measures were
available.
Subnormal developmental outcome
was defined as an IQ between 78 and 93
and/or an M-ABC score between the
15th and the 5th percentile and/or a neu-
rological examination total score be-
tween 50% and 75% and/or a borderline
CBCL total problem score without any
of the scores in the abnormal range.
510.e3 American Journal of Obstetrics& GynecoloFIGURE 1
Number of participants and reasons for
dropout until the 4.5 year follow-up
vanWassenaer. Child outcome after severe hypertensive pregnancy complications. Am J Obstet Gynecol 2011.gy JUNE 2011
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www.AJOG.org Obstetrics ResearchAbnormal developmental outcome was
defined as an IQ below 78 and/or an M-
ABC score up or below the 5th percentile
and/or a neurological examination total
score below 50% and/or a clinical CBCL
total problem score.
Abnormal composite outcome was
defined as fetal or neonatal mortality or
abnormal developmental outcome.
The Committee of Medical Ethics in
both the Academic Medical Center and
the Vrije Universiteit University Medi-
cal Center in Amsterdam (The Nether-
lands) approved this follow-up study.
Statistical analysis
Statistical analyses were performed with
SPSS 16.0.2 (SPSS Inc, Chicago, IL). Dif-
ferences were considered statistically sig-
nificant at P .05.
First, the association of the 4.5 year
outcome with trial allocation was ana-
lyzed by using 2 tests (2 sided), Student
t tests, and nonparametric Mann-Whit-
neyU tests, when appropriate. Second, it
as intended to analyze the complete co-
ort for further explorationof data in the
bsence of differences in relation to trial
TABLE 2
Baseline characteristics until deliv
Characteristic
Total number of participants at 4.5 y correcte
...................................................................................................................
HELLP syndrome, n (%)
...................................................................................................................
Severe preeclampsia, n (%)
...................................................................................................................
Fetal growth restriction, n (%)
...................................................................................................................
Major maternal morbidity, n (%)
...................................................................................................................
Corticosteroids for fetal lung maturation, n (%
...................................................................................................................
Umbilical artery maximal PI, mean range
...................................................................................................................
Highest U/C ratio, mean range
...................................................................................................................
Prolongation of pregnancy (d), mean, range
...................................................................................................................
Gestational age at delivery (wks), mean range
...................................................................................................................
Birthweight (g), mean range
...................................................................................................................
Birthweight ratio, mean range
...................................................................................................................
pH umbilical artery, mean range
...................................................................................................................
Apgar score 5 min, mean range
...................................................................................................................
Apgar score 5 min 7, n (%)
...................................................................................................................
Infant sex, female, n (%)
...................................................................................................................
HELLP, hemolysis, elevated liver enzymes, and low platelet co
vanWassenaer. Child outcome after severe hypertensive pllocation, as has been done in earlierublications.15,16,27 For the complete co-
ort, logistic regression was done to find
redictors of abnormal developmental
utcome (abnormal vs not abnormal).
In addition, linear regression analyses
ere done with IQ,motor scores, neuro-
ogical scores, and behavioral scores as 4
eparate dependent outcomes. The sets
ntered in the stepwise regression analy-
es were as follows: The first set com-
rised sociodemographic variables (ie,
aternal and paternal education and
thnic background). The second set
omprised variables during maternal
isease and childbirth (ie, HELLP syn-
rome, major maternal morbidity, the
ighest ratio of the umbilical artery di-
ided by the median cerebral artery pul-
atility index (U/C ratio), highest systolic
nd diastolic blood pressure, gestational
ge at delivery, BWR, sex, andApgar score
t 5 minutes less than 7). The third set
omprisedmajor neonatal morbidity.
RESULTS
The trial included 216 women and fe-
tuses. Figure 1 presents the study flow-
Value
e n  149
..................................................................................................................
61 (40.9)
..................................................................................................................
113 (75.8)
..................................................................................................................
135 (90.6)
..................................................................................................................
16 (10.7)
..................................................................................................................
113 (75.8)
..................................................................................................................
1.58 (0.74–4.77)
..................................................................................................................
1.22 (0.30–4.17)
..................................................................................................................
8.4 (0–44)
..................................................................................................................
31.4 (27.3–38.4)
..................................................................................................................
1281.0 (625–2960)
..................................................................................................................
0.68 (0.33–1.05)
..................................................................................................................
7.23 (6.64–7.35)
..................................................................................................................
9 (1–10)
..................................................................................................................
14 (9)
..................................................................................................................
77 (51.7)
..................................................................................................................
ancy complications. Am J Obstet Gynecol 2011.chart. At age 4.5 years, 174 children were
JUNE 2011 Americinvited for follow-up.Of these 174, 6 had
moved abroad, whereas the parents of 11
did not respond or could not be traced,
and the parents of 8 children refused fol-
low-up (Figure 1). Thus, a total of 149
children (86%) participated.
It was not possible to perform all as-
sessments as planned in 20 children. Be-
cause of practical problems, related to re-
fusal of parents to come to the clinic at a
time when all investigators could be pres-
ent, neurological and/or motor assess-
ment was not done in 11 children. Be-
cause of noncooperative behavior and/or
language problems, the IQ test was not
reliable in 4 children. In another 5, par-
ents did not want their child to partici-
pate in neurodevelopmental assessments
but did fill in the behavior questionnaire.
For 144 children (84%), results on 2 or
more developmental domains were
available.
The 149 responders were not different
from 25 nonresponders regarding ma-
ternal characteristics, trial allocation,
and neonatal disease but differed on 1
year neurological outcome. All nonre-
sponders had a normal neurological
outcome at 12 months corrected age,
whereas 85% of the responders had a
normal neurological outcome at age 12
months (P .042).
Because there were no differences in
relation to trial allocation in perinatal
characteristics or developmental out-
comes, all analyses were presented for
the complete cohort.
In Tables 2 and 3, baseline character-
istics of the children available for fol-
low-up are presented. Forty-one percent
of the mothers had HELLP syndrome
and 76% severe preeclampsia (many ful-
filled both diagnoses, as pregnancy
evolved27). Most of the highest U/C ra-
tios measured during maternal admis-
sion were in the abnormal range (0.7).
Mean BWR of our patient group was
0.68 (which is comparable with P2.3 of
conventional growth chart), demon-
strating the high degree (90%were SGA)
of growth restriction in our cohort. The
mean gestational age at birth was 31
weeks (range, 27–38 weeks), whereas
pregnancywas prolongedwith amean ofery
d ag
.........
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.........
.........
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)
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.........
.........
.........
.........
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.........
.........
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.........
unt.8.4 days aftermaternal admission.Major
an Journal of Obstetrics& Gynecology 510.e4
h
d
(
o
s
e
t
e
1
e
m
w
h
i
s
(
d
d
i
w
p
h
I
2
d
c
w
(
n
a
s
w
(
v
a
2
3
t
v
i
O
r
regn
Research Obstetrics www.AJOG.orgneonatal morbidities were relatively in-
frequent (11%).
Developmental outcome
at age 4.5 years
In Table 4, outcomes on the 4 develop-
mental tests are shown. IQ was within
the normal range in 70% of the partici-
pants, whereas 20% scored moderately
abnormal and another 10% scored ab-
normal. Compared with the normal dis-
tribution of intelligence, in which 14%
received a moderately delayed and 2% a
severely delayed score, more cognitive
problems were therefore present in our
cohort of children born from mothers
with early and severe hypertensive com-
plications of pregnancy. The mean IQ
was 8 points lower than in the normal
population.
On the motor test (M-ABC), 11% of
participants received a subnormal score
and another 9% an abnormal score. This
is 10%, respectively, 5% for the norm
population, with a median score of 4. In
this study, the median score was 4.5
(mean 6.2), which is comparable with
the normal population. None of the par-
ticipants had the maximum impairment
score of 40.
The neurological examination re-
vealed in 12% a subnormal score and
only 4 children (3%) had an abnormal
score (cerebral paresis).
Behavioral scores were subnormal in
4% and abnormal in 8%. Based on nor-
mative data, a number of 10% is ex-
pected in the abnormal range and an-
other 8% in the subnormal range. Also,
when scores were split into internalizing
and externalizing behavior, no differ-
enceswith the normal groupwere found.
In our study population, the percentages
of behavior problems varied for total, in-
ternalizing, and externalizing scores be-
tween 8.1% and 11.6 %.
The outcomes on these 4 developmen-
tal tests were not different in children
born after maternal HELLP, severe pre-
eclampsia, or fetal growth restriction in
combination with pregnancy induced
hypertension.
In Table 5, developmental outcome is
shown. In recent literature inwhich term
control groups are used, 75-80% of term
born, normal birthweight children are y
510.e5 American Journal of Obstetrics& Gynecolodescribed to have a developmental out-
comewithout any disability.27 In this co-
ort, 54% of the children had a normal
evelopmental outcome. Twenty-nine
20%) had an abnormal developmental
utcome. Ten children (6.8%) in the
tudy population were attending special
ducation classes. At the age of 4.5 years,
hat is about 7 times as many as could be
xpected based on a nationwide figure of
% at that age. All children in the special
ducation classes except 1 had an abnor-
al developmental outcome. There
ere no blind or deaf children in the co-
ort, but 2 children were wearing hear-
ng aids, with sufficient hearing for
peech development.
Next we studied composite outcome
including fetal or neonatal death and
evelopmental outcome). Of 182 chil-
ren with a known outcome (216 total
nclusions minus 34 surviving children
ith no or insufficient data at age 4.5
TABLE 3
Baseline characteristics until the c
Characteristic
Major neonatal morbidity
..........................................................................................................
Total
..........................................................................................................
CLD (36 wks)
..........................................................................................................
ICH grades 3 and 4
..........................................................................................................
PVL grades 2, 3, and 4
...................................................................................................................
Necrotizing enterocolitis
...................................................................................................................
Sepsis
...................................................................................................................
Ductus botalli
...................................................................................................................
Baylet Scales of Infant Development, at 12 m
..........................................................................................................
MDI
.................................................................................................
Mean (SD)
.................................................................................................
MDI normal
.................................................................................................
MDI less than –1 SD (greater than –2
.................................................................................................
MDI less than –2 SD
..........................................................................................................
PDI
.................................................................................................
Mean (SD)
.................................................................................................
PDI normal
.................................................................................................
PDI less than –1 SD (greater than –2 S
.................................................................................................
PDI less than –2 SD
...................................................................................................................
CLD, chronic lung disease; IVH, intraventricular hemorrhage;
mental index; PVL, periventricular leucomalacia.
vanWassenaer. Child outcome after severe hypertensive pears), 67 (37%) had an abnormal com- g
gy JUNE 2011osite outcome (38 infants died and 29
ad abnormal developmental outcome).
f abnormal developmental outcome in
0% of the children without sufficient
ata is also assumed, then abnormal out-
ome of the initial group of 216 fetuses
ould be 34%.
The relation of composite outcome
fetal, neonatal death and normal, sub-
ormal, abnormal or missing outcome
t age 5 years) with gestational age in
hown in Figure 2, A and with birth-
eight in Figure 2, B. Perinatal mortality
n  38, 17.6% of 216) was equally di-
ided between fetal and neonatal death
nd was 70% in children born at 26 and
7 weeks gestational, whereas this was
0% at 28 and 29 weeks. Whereas mor-
ality decreased below 5%, abnormal de-
elopmental outcome rate was still 30%
n children born at 30 and 31 weeks.
verall outcomes were best for child-
en born after 31 completed weeks of
ected age of 1 y (n  149)
Value
..................................................................................................................
16 (10.7)
..................................................................................................................
13 (8.7)
..................................................................................................................
2 (1.3)
..................................................................................................................
2 (1.3)
..................................................................................................................
3 (2.0)
..................................................................................................................
68 (45.6)
..................................................................................................................
7 (4.7)
..................................................................................................................
..................................................................................................................
..................................................................................................................
88.0 (9.5)
..................................................................................................................
89 (61.4)
..................................................................................................................
54 (37.2)
..................................................................................................................
2 (1.4)
..................................................................................................................
..................................................................................................................
79.9 (13.2)
..................................................................................................................
41 (28.5)
..................................................................................................................
79 (54.9)
..................................................................................................................
24 (16.7)
..................................................................................................................
mental developmental index; PDI, psychomotor develop-
ancy complications. Am J Obstet Gynecol 2011.orr
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www.AJOG.org Obstetrics ResearchIn Figure 2, B, it is shown that the peri-
atal mortality was 70% in infants with a
irthweight less than 750 g, 11-15% in
nfants with a birthweight of 750-1250 g,
nd 1% in infants with higher birth-
TABLE 4
Outcome at 4.5 y corrected age on
Characteristic
Number of participants at 4.5 years corrected
...................................................................................................................
IQ
..........................................................................................................
Mean IQ (SD)
.................................................................................................
Normal
.................................................................................................
Subnormal
.................................................................................................
Abnormal
...................................................................................................................
M-ABC, motor score
..........................................................................................................
Mean score (SD)
..........................................................................................................
Mean percentile score (SD)
.................................................................................................
Normal
.................................................................................................
Subnormal
.................................................................................................
Abnormal
...................................................................................................................
Neurological score
..........................................................................................................
Mean percentage score (SD)
.................................................................................................
Normal
.................................................................................................
Subnormal
.................................................................................................
Abnormal
...................................................................................................................
CBCL behavior score
..........................................................................................................
Mean T-score (SD)
..........................................................................................................
Normal
..........................................................................................................
Subnormal
..........................................................................................................
Abnormal
...................................................................................................................
CBL, Child Behavior Checklist; M-ABC, Movement Assessmen
vanWassenaer. Child outcome after severe hypertensive p
TABLE 5
Developmental outcome at 4.5 y co
Characteristic
Number of participants at 4.5 y corrected
..........................................................................................................
Normal outcome on all tests
..........................................................................................................
Subnormal outcome on 1 domain, normal
..........................................................................................................
Subnormal outcome on 2 tests
..........................................................................................................
Abnormal outcome on 1 test
..........................................................................................................
Abnormal outcome on 2 tests
...................................................................................................................
a Only participants who completed at least 2 of the 4 developm
1 or 2 missing scores, the worst score on the available d
assumed for the missing scores.vanWassenaer. Child outcome after severe hypertensive pregnweight. With increasing birthweight,
mortality decreased and the percentage
of children with normal developmental
outcome improved to 48% in the highest
weight category. Normal survival in chil-
different developmental tests
Value
e Total (n 149)
..................................................................................................................
n  140
..................................................................................................................
99.6 ( 14.4)
..................................................................................................................
98 (70%)
..................................................................................................................
28 (20%)
..................................................................................................................
14 (10%)
..................................................................................................................
n  136
..................................................................................................................
6.2 (6.1)
..................................................................................................................
45.1 (29.6)
..................................................................................................................
109 (80.1%)
..................................................................................................................
15 (11.0%)
..................................................................................................................
12 (8.8%)
..................................................................................................................
n  137
..................................................................................................................
82.9 ( 13.7)
..................................................................................................................
117 (85.4%)
..................................................................................................................
16 (11.7%)
..................................................................................................................
4 (2.9%)
..................................................................................................................
n  148
..................................................................................................................
48.4 (10.4)
..................................................................................................................
130 (87.8%)
..................................................................................................................
6 (4.1%)
..................................................................................................................
12 (8.1%)
..................................................................................................................
ttery for Children.
ancy complications. Am J Obstet Gynecol 2011.
cted age
Value
n 144a
..................................................................................................................
77 (53.5%)
..................................................................................................................
other 3 tests 32 (22.2%)
..................................................................................................................
6 (4.2%)
..................................................................................................................
19 (13.2%)
..................................................................................................................
10 (6.9%)
..................................................................................................................
l tests were included in this analysis. For 15 children with
ns were used for categorization, whereas normality wasancy complications. Am J Obstet Gynecol 2011.
JUNE 2011 Americdren born after 27 weeks’ gestational age
or with a birthweight greater than 750 g
was between 50% and 60%.
Multivariate analyses
Non-Caucasian ethnic background (P
006), low paternal education (P .03),
nd lowU/C ratio (P .01) were associ-
ted with lower IQ scores. Gestational
ge, birthweight, and birthweight ratio
ere not associated with IQ, in neither
nivariate analyses nor the multivariate
odel. Male sex (P  .018) and major
eonatal morbidity (P  .015), but no
actors related to pregnancy complica-
ions, were associated with worse motor
core results. Male sex (P  .000) and
ow Apgar score, a marker of both
hronic and acute placental insuffi-
iency, (P  .036) were associated with
orse neurological scores.
Higher (worse) behavior scores were
ssociated with lower maternal educa-
ion (P .018) and composite maternal
morbidity (P .04). Abnormal develop-
mental outcome was associated with
male sex (P  .027), lower birthweight
ratio (P  .034), and lower gestational
age at birth (P .006). If, in an otherwise
similar analysis, BWR was replaced by
birthweight, gestational age was no lon-
ger statistically significant, and birth-
weight (P .018) andmale sexwere then
significantly associated with abnormal
outcome.
COMMENT
This is one of the few prospective studies
describing early schoolage outcome in a
cohort of children born from mothers
presenting with severe hypertensive
complications of pregnancy between 24
and 34 weeks of gestation. It also in-
cludes, apart from neurodevelopmental
outcome, data on fetal and postnatal
loss.
All mother-child pairs were partici-
pating in a randomized trial in which 2
strategies of expectant management were
compared. Because primary and devel-
opmental outcomes did not differ be-
tween trial groups, they were combined
for this study. Our child outcome can
thus be regarded as an evaluation of ex-
pectant management of early-onset pre-the
ag
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Research Obstetrics www.AJOG.orggrowth restriction with pregnancy-in-
duced hypertension, which are part of
the same clinical entity.11,28
In these pregnancies, fetal growth re-
striction is prevalent. In our cohort of 4.5
year old children, mean BWR was 0.68
using customized growth charts, which
is equivalent to the p2.3 of traditional
growth charts, and 90% was below p10.
To evaluate risks and benefits of obstet-
rical treatment choices in these high-risk
pregnancies, fetal andneonatalmortality
alongwith long termneurodevelopmen-
tal outcome should be evaluated. Evalu-
ation of short-term neonatal morbidity
is insufficient because it poorly predicts
neurodevelopment.2
Of the 216 fetuses included in the
study, we were able to report composite
outcome in 182 (89%). Composite out-
come was abnormal in 67 fetuses, 37%.
Thirty-eight died and 29 had an abnor-
mal developmental outcome at age 4.5
years. Had we reported on only the sur-
viving children, the percentage of chil-
dren with an abnormal developmental
outcome would have been 20% (29 of
144).
Abnormal developmental outcome
was associated with male sex and either
the combination of BWRand gestational
age at birth, or birthweight alone, but not
with other maternal disease–related fac-
tors. We also demonstrated the balance
between mortality and abnormal devel-
opmental outcome.With increasing ges-
tational age or birthweight, mortality
rapidly declined, but initially abnormal
development increased. We are not
aware of other studies showing this, in a
comparable cohort of children born af-
ter severe hypertensive complications of
pregnancy.
Apart from studying risk factors for
abnormal composite or developmental
outcome in the total cohort, studying
predictors of developmental outcomes
are useful because they may help to fur-
ther delineate the causes of brain dam-
age. Surviving children in our cohort
were born at a mean gestational age of
31.4 weeks (range, 27–38) and with
birthweights ranging from 625 to 2960 g,
whereas 90% were growth restricted at
birth, on the basis of customized growth
charts.28,29 Prolongation of pregnancy o
510.e7 American Journal of Obstetrics& Gynecoloas at average 8.5 days. In particular,
egarding IQ, children in our cohort
ad lower scores than in the general
opulation.
We found no effect of gestational age,
irthweight, or BWR on the IQ scores in
linear regression analysis. Sociodemo-
raphic variables, and a higher degree of
rain sparing (ie, a higher U/C ratio),
ere associated with higher IQ scores in
FIGURE 2
Outcomes at 4.5 years, including p
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A  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
n=29 n=47 n=57
26/27 28/29 30/31
B  
0%
20%
40%
60%
80%
100%
n=38 n=41 n=36
<750 750-
1000
1000-
1250
A, Relationship of composite outcome with gest
ith birthweight.
vanWassenaer. Child outcome after severe hypertensive pregur multivariate model. In a less homo-
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hich 20% was growth restricted, about
0% had a raised U/C ratio (0.72) in
tero.30 In our cohort, 95% had a raised
U/C ratio. Placental function was there-
fore suboptimal in almost all cases, and
apparently thenmore brain sparing is an
appropriate adaptivemechanism to pro-
tect brain maturation.
In addition, neurological and behav-
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www.AJOG.org Obstetrics Researchtors connected with pregnancy-related
complications (lowApgar score andma-
ternal morbidity, respectively), apart
from sociodemographic factors. In mo-
tor outcome, neonatal and not maternal
morbidity played a role.
Our findings are in agreement with
those described by Hutton et al,31 in
which SGA status was found to be more
associated with cognitive outcome and
preterm status more with motor out-
come. Whether the relative low occur-
rence of motor problems was related to
the aforementioned protective effect of
pregnancy-related hypertension on in-
traventricular hemorrhage and cerebral
palsy8,9 is the question. A study using
rowth-restricted piglets showed that
here is an improved ability to withstand
ritical periods of gradual oxygen deficit
ith improvement of cerebrovascular au-
oregulation during hemorrhagic hypo-
ension in growth-restricted animals.32 In
ur study, only 4 children had cerebral
alsy (3%), which is not above the ex-
ected cerebral palsy rates on the basis of
opulation-basedprevalence in relation to
estational age.33
Contrary to findings in previous stud-
ies,2 behavioral scores were not different
from the normal population. In a recent
report, especially more externalizing be-
havior problems were found in 8-14 year
old children born from mothers with
preeclampsia, whereas at 5 years of age,
there was a reduction in internalizing
problem behaviors in the same cohort.34
Possibly the age of 4-5 years is too young
to find problem behaviors. Interestingly,
in our cohort, behavior scores were
higher if mothers had had a more com-
plicated clinical course of pregnancy.
This findingmay help to set up strategies
for postpregnancy psychological sup-
port after hypertensive complications.
This could improve child behavior as
well.35
Reporting prospectively collected out-
comes in homogeneous cohorts of wo-
men with hypertensive complications of
pregnancy until schoolage of the off-
spring is pivotal for development of fu-
ture treatments. Apart from maternal
complications, composite child out-
come should be the endpoint of trials
comparing management strategies of se-vere and early hypertensive complica-
tions of pregnancy.
Points for clinical implication
There are several clinical implications to
be considered. First, there is scarce infor-
mation on child outcome after early-on-
set and severe hypertensive complica-
tions of pregnancy. Second, this study, in
which women with early-onset and se-
vere hypertensive complications of preg-
nancy were treated with expectant man-
agement, perinatal death, or abnormal
child development at age 4.5 years oc-
curred in 37%. Lastly, child outcome
should be defined by a compositemeasure
consisting of perinatal death or abnormal
child development in studies aiming to
compare obstetrical management strate-
gies in these high-risk pregnancies. f
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